Search Results for: covid-19
FORMULATION FORUM – Application of Captisol® Technology to Enable the Formulation of Remdesivir in Treating COVID-19 June 4, 2020
James Pipkin, PhD, Vince Antle, PhD, and Rebecca Garcia-Fandiño, PhD, explain why more Captisol® than ever is required to meet Gilead’s bold goals of making remdesivir available to COVID-19 patients in the US and to hundreds of countries around the world.
FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients May 26, 2020
The US FDA has recently approved the investigational new drug (IND) application submitted by Octapharma USA for a Phase 3 clinical trial on…
CanSino Biologics & Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine May 20, 2020
CanSino Biologics Inc. and Precision NanoSystems (PNI) recently announced a co-development agreement of a mRNA lipid nanoparticle (mRNA-LNP) vaccine against COVID-19. The parties will…
COVID-19’s Effect Will Boost Infectious Disease Drug Approvals & Present Opportunities to CMOs May 19, 2020
In response to the global pandemic, biopharma companies have put a renewed emphasis on finding treatments for infectious diseases, including COVID-19 and other infectious diseases overall…..
Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP May 19, 2020
Akers Biosciences, Inc. recently announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic…..
Singota Solutions Collaborates With Noveome Biotherapeutics to Manufacture Promising Therapy to Treat Severe Condition in People Infected with COVID-19 May 13, 2020
Singota Solutions has been selected to collaborate with Noveome Biotherapeutics, Inc. to manufacture the ST266 investigational drug product, a biologic being evaluated in….
Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines May 6, 2020
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced the availability of contract test services to support….
Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine May 5, 2020
Arcturus Therapeutics Holdings Inc. and Catalent, Inc.recently announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to….